20716-7 |
Bovine diarrhea virus |
PrThr |
Ser |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Bovine diarrhea virus [Presence] in Serum by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20716-7 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
BVDV Ser Ql Cult |
|
|
|
|
|
BDV; Beef; Bovine viral diarrhea; BVD; BVDV; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Mucosal disease; Ordinal; Pestivirus; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Spec; SR; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20717-5 |
Bovine diarrhea virus 2 Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Bovine diarrhea virus 2 Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20717-5 |
|
IF |
|
|
Both |
|
|
|
0 |
BVDV2 Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; BDV; Beef; Bovine viral diarrhea; BVD; BVDV; BVDV2; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Mucosal disease; Ordinal; Pestivirus; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20718-3 |
Bromide |
MCnc |
Ocular fld |
Pt |
Qn |
|
|
ACTIVE |
Bromide [Mass/volume] in Ocular fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
20718-3 |
|
|
|
|
Both |
|
|
|
0 |
Bromide Ocflu-mCnc |
|
|
|
Y |
|
BR; DRUG/TOXICOLOGY; Drugs; Eye fluid; Level; Mass concentration; Occular Fluid; OcFlu; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0m |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
20719-1 |
Brucella abortus Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl.standard tube |
|
ACTIVE |
Brucella abortus Ab [Titer] in Serum by Tube agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
20719-1 |
|
Aggl.standard tube |
|
|
Both |
|
|
|
0 |
B abortus Ab Titr Ser Tube aggl |
|
|
|
Y |
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; TA; Titer; Titered; Titre; Ttr; Tube aggl; Undulant fever; Vet; Veterinary |
2.75 |
1.0m |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
2072-7 |
Chloride |
SCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
2072-7 |
|
|
|
|
Both |
|
|
|
0 |
Chloride Fld-sCnc |
|
|
|
Y |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Cl; Cl-; Fl; Fld; FLU; Fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.73 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
20720-9 |
Brucella abortus Ab |
PrThr |
Milk |
Pt |
Ord |
Aggl.serial ring test |
|
ACTIVE |
Brucella abortus Ab [Presence] in Milk by Serial ring agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20720-9 |
|
Aggl.serial ring test |
|
|
Both |
|
|
|
0 |
B abortus Ab Mlk Ql Ser ring aggl |
|
|
|
|
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; BRT; Bruc; Brucellosis; Contagious abortion; ID; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Ser ring aggl; Undulant fever; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20721-7 |
Brucella abortus Ab |
PrThr |
Semen |
Pt |
Ord |
Aggl |
|
ACTIVE |
Brucella abortus Ab [Presence] in Semen by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20721-7 |
|
Aggl |
|
|
Both |
|
|
|
0 |
B abortus Ab Smn Ql Aggl |
|
|
|
|
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; Ejaculate; Genitourinary; GU; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sem; Seminal fluid; Smn; SMPLS; Undulant fever; URO; Urology; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20722-5 |
Brucella abortus Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl.rivanol |
|
ACTIVE |
Brucella abortus Ab [Titer] in Serum by Rivanol agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
20722-5 |
|
Aggl.rivanol |
|
|
Both |
|
|
|
0 |
B abortus Ab Titr Ser Rivanol aggl |
|
|
|
Y |
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Rivanol aggl; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Undulant fever; Vet; Veterinary |
2.75 |
1.0m |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
20723-3 |
Brucella abortus Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl.rapid |
|
ACTIVE |
Brucella abortus Ab [Presence] in Serum by Rapid agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20723-3 |
|
Aggl.rapid |
|
|
Both |
|
|
|
0 |
B abortus Ab Ser Ql Rapid aggl |
|
|
|
|
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rapid aggl; Screen; Serum; SR; Undulant fever; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20724-1 |
Brucella abortus Ab |
PrThr |
Whey |
Pt |
Ord |
Aggl.ring test |
|
ACTIVE |
Brucella abortus Ab [Presence] in Whey by Ring agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20724-1 |
|
Aggl.ring test |
|
|
Both |
|
|
|
0 |
B abortus Ab whey Ql Ring aggl |
|
|
|
|
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; BRT; Bruc; Brucellosis; Contagious abortion; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ring aggl; Screen; Undulant fever; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20725-8 |
Brucella abortus Ab |
PrThr |
Milk |
Pt |
Ord |
Aggl.ring test |
|
ACTIVE |
Brucella abortus Ab [Presence] in Milk by Ring agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20725-8 |
|
Aggl.ring test |
|
|
Both |
|
|
|
0 |
B abortus Ab Mlk Ql Ring aggl |
|
|
|
|
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; BRT; Bruc; Brucellosis; Contagious abortion; ID; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ring aggl; Screen; Undulant fever; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20726-6 |
Brucella abortus Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl.card |
|
ACTIVE |
Brucella abortus Ab [Presence] in Serum by Card agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20726-6 |
|
Aggl.card |
|
|
Both |
|
|
|
0 |
B abortus Ab Ser Ql Card aggl |
|
|
|
|
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Card aggl; Contagious abortion; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Undulant fever; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20727-4 |
Brucella abortus Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl.plate.buffered acidified |
|
ACTIVE |
Brucella abortus Ab [Presence] in Serum by Acidified buffered plate agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20727-4 |
|
Aggl.plate.buffered acidified |
|
|
Both |
|
|
|
0 |
B abortus Ab Ser Ql Buff plate aggl |
|
|
|
|
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; BAPA; Bovine brucellosis; Bruc; Brucellosis; Buff plate aggl; Contagious abortion; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Plate aggl; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Undulant fever; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20728-2 |
Brucella abortus Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Brucella abortus Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20728-2 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
B abortus Ab Ser Ql CF |
|
|
|
|
|
Abort; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; CF; Comp fixation; Compfix; Complement fixation; Contagious abortion; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Undulant fever; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20729-0 |
Brucella abortus Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl.plate |
|
ACTIVE |
Brucella abortus Ab [Titer] in Serum by Plate agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
20729-0 |
|
Aggl.plate |
|
|
Both |
|
|
|
0 |
B abortus Ab Titr Ser Plate aggl |
|
|
|
Y |
|
Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Plate aggl; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Undulant fever; Vet; Veterinary |
2.75 |
1.0m |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
2073-5 |
Chloride |
SCnc |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
2073-5 |
|
|
|
|
Both |
|
|
|
0 |
Chloride RBC-sCnc |
|
|
|
Y |
|
Chemistry; Cl; Cl-; Erythrocytes; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration |
2.34 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
20730-8 |
Brucella abortus Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Brucella abortus Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20730-8 |
|
IA |
|
|
Both |
|
|
|
0 |
B abortus Ab Ser Ql IA |
|
|
|
|
|
Abort; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Undulant fever; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
20731-6 |
Brucella abortus Ab |
PrThr |
Ser |
Pt |
Ord |
EIA.RST |
|
ACTIVE |
Brucella abortus Ab [Presence] in Serum by Immunoassay (EIA) RST |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20731-6 |
|
EIA.RST |
|
|
Both |
|
|
|
0 |
B abortus Ab Ser Ql EIA RST |
|
|
|
|
|
Abort; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; EIA RST; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Undulant fever; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20732-4 |
Brucella ovis Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Brucella ovis Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20732-4 |
|
IA |
|
|
Both |
|
|
|
0 |
B ovis Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B ovis; Bruc; Brucellosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Ovine epididymitis; Point in time; PR; QL; Qual; Qualitative; Ram epididymitis; Random; Screen; Serum; SR; SUDS; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
20733-2 |
Brucella ovis Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Brucella ovis Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20733-2 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
B ovis Ab Ser Ql CF |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B ovis; Bruc; Brucellosis; CF; Comp fixation; Compfix; Complement fixation; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Ovine epididymitis; Point in time; PR; QL; Qual; Qualitative; Ram epididymitis; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20734-0 |
Brucella sp |
Prid |
Tiss |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Brucella sp identified in Tissue by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20734-0 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Brucella Tiss Cult |
|
|
|
|
|
Bruc; Brucellosis; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Spec; species; spp; Tissue; Tissue, unspecified |
2.79 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
20735-7 |
Brucella sp |
Prid |
Milk |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Brucella sp identified in Milk by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20735-7 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Brucella Mlk Cult |
|
|
|
|
|
Bruc; Brucellosis; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Nominal; Point in time; Random; Spec; species; spp |
2.79 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
20736-5 |
Cache valley virus Ab.Neut |
PrThr |
Ser |
Pt |
Ord |
Neut |
|
ACTIVE |
Cache valley virus neutralizing antibody [Presence] in Serum by Neutralization test |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20736-5 |
|
Neut |
|
|
Both |
|
|
|
0 |
CVV NAb Ser Ql Nt |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; CVV; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Orthobunyaviruses; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Serum virus neutralization; SR; SVN; Virus neutralization test; VNT |
2.72 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20737-3 |
Cadmium |
MCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Cadmium [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
ug/g |
|
|
|
|
|
|
DRUG/TOX |
|
20737-3 |
|
|
|
|
Both |
|
|
|
0 |
Cadmium Tiss-mCnt |
|
|
|
Y |
|
CD; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified |
2.4 |
1.0m |
|
|
|
|
|
|
|
ug/g |
|
|
|
0 |
20738-1 |
Campylobacter sp |
Prid |
Isolate |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Campylobacter sp identified in Isolate by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20738-1 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Campylobacter Islt Cult |
|
|
|
|
|
C&S; Campy; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Spec; species; spp |
2.78 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |